Diagnosing migraine in children and adolescence using ID migraine: results of an Italian multicenter validation.

IF 2.7 4区医学 Q2 CLINICAL NEUROLOGY

Neurological Sciences Pub Date : 2025-03-27 DOI:10.1007/s10072-025-08076-z

Ilaria Frattale, Vittorio Sciruicchio, Daniela D'Agnano, Vincenzo Raieli, Salvatore Lo Cascio, Giuseppe Santangelo, Edvige Correnti, Fabiana Ursitti, Giorgia Sforza, Gabriele Monte, Luigi Mazzone, Massimiliano Valeriani, Laura Papetti

{"title":"Diagnosing migraine in children and adolescence using ID migraine: results of an Italian multicenter validation.","authors":"Ilaria Frattale, Vittorio Sciruicchio, Daniela D'Agnano, Vincenzo Raieli, Salvatore Lo Cascio, Giuseppe Santangelo, Edvige Correnti, Fabiana Ursitti, Giorgia Sforza, Gabriele Monte, Luigi Mazzone, Massimiliano Valeriani, Laura Papetti","doi":"10.1007/s10072-025-08076-z","DOIUrl":null,"url":null,"abstract":"Background: Since migraine is the most frequent neurological condition, an early diagnosis is important to limit the impact of the disease on the quality of life. Although migraine diagnosis is based on the International Classification of Headache Disorders 3rd edition (ICHD3) criteria, other briefer questionnaires have been developed, especially for screening purpose. While the three-item ID Migraine has proved useful for migraine diagnosis in adulthood, no validated tools are available for children and adolescents. The aim of this study is to validate ID Migraine also in pediatric patients.Results: The Italian ID Migraine for adulthood was completed by 289 pediatric patients (mean age 12.14 ± 3.15, range 6-17) who attended three third-level pediatric headache centers. Clinical and neurological examinations were performed, and the final diagnosis was reached according to the ICHD3 criteria. The migraine group consisted of 230 patients, and the control group consisted of 59 patients who received headache diagnoses different from migraine. We considered the ID migraine positive whether 2 out of 3 responses were 'yes'. ID migraine for diagnosis of pediatric migraine showed a sensitivity of 0.86 (86%), a specificity of 0.95 (95%), a positive predictive value (PPV) of 0.98 (98%) and a negative predictive value (NPV) 0.64 (64%).Conclusion: ID Migraine can be considered a valid tool for migraine diagnosis also in pediatric age, starting from the age of 6 years.","PeriodicalId":19191,"journal":{"name":"Neurological Sciences","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurological Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10072-025-08076-z","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Since migraine is the most frequent neurological condition, an early diagnosis is important to limit the impact of the disease on the quality of life. Although migraine diagnosis is based on the International Classification of Headache Disorders 3rd edition (ICHD3) criteria, other briefer questionnaires have been developed, especially for screening purpose. While the three-item ID Migraine has proved useful for migraine diagnosis in adulthood, no validated tools are available for children and adolescents. The aim of this study is to validate ID Migraine also in pediatric patients.

Results: The Italian ID Migraine for adulthood was completed by 289 pediatric patients (mean age 12.14 ± 3.15, range 6-17) who attended three third-level pediatric headache centers. Clinical and neurological examinations were performed, and the final diagnosis was reached according to the ICHD3 criteria. The migraine group consisted of 230 patients, and the control group consisted of 59 patients who received headache diagnoses different from migraine. We considered the ID migraine positive whether 2 out of 3 responses were 'yes'. ID migraine for diagnosis of pediatric migraine showed a sensitivity of 0.86 (86%), a specificity of 0.95 (95%), a positive predictive value (PPV) of 0.98 (98%) and a negative predictive value (NPV) 0.64 (64%).

Conclusion: ID Migraine can be considered a valid tool for migraine diagnosis also in pediatric age, starting from the age of 6 years.

查看原文本刊更多论文

使用ID偏头痛诊断儿童和青少年偏头痛：意大利多中心验证的结果。

背景：由于偏头痛是最常见的神经系统疾病，早期诊断对于限制疾病对生活质量的影响非常重要。虽然偏头痛的诊断是基于国际头痛疾病分类第3版（ICHD3）标准，但已经开发了其他更简短的问卷，特别是用于筛查目的。虽然三项ID偏头痛已被证明对成年期偏头痛的诊断有用，但没有有效的工具可用于儿童和青少年。本研究的目的是验证儿童患者的偏头痛。结果：289名儿童患者（平均年龄12.14±3.15岁，范围6-17岁）在三个三级儿童头痛中心完成了成年期意大利ID偏头痛研究。进行临床和神经学检查，并根据ICHD3标准进行最终诊断。偏头痛组由230名患者组成，对照组由59名患者组成，他们的头痛诊断与偏头痛不同。如果3个回答中有2个为“是”，我们认为偏头痛是阳性的。ID偏头痛诊断小儿偏头痛的敏感性为0.86(86%)，特异性为0.95(95%)，阳性预测值（PPV）为0.98(98%)，阴性预测值（NPV）为0.64（64%）。结论：从6岁开始，ID偏头痛也可以被认为是儿童年龄偏头痛诊断的有效工具。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neurological Sciences 医学-临床神经学

CiteScore

6.10

自引率

3.00%

发文量

743

审稿时长

4 months

期刊介绍： Neurological Sciences is intended to provide a medium for the communication of results and ideas in the field of neuroscience. The journal welcomes contributions in both the basic and clinical aspects of the neurosciences. The official language of the journal is English. Reports are published in the form of original articles, short communications, editorials, reviews and letters to the editor. Original articles present the results of experimental or clinical studies in the neurosciences, while short communications are succinct reports permitting the rapid publication of novel results. Original contributions may be submitted for the special sections History of Neurology, Health Care and Neurological Digressions - a forum for cultural topics related to the neurosciences. The journal also publishes correspondence book reviews, meeting reports and announcements.